Track Jupiter Life Line Hospitals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -1.49 %
Low
301.2
High
326.9
1 Month returns: 7.52 %
Low
290.2
High
340.0
1 Year returns: 8.52 %
Low
230.4
High
340.0
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Jupiter Life Line Hospitals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Jupiter Life Line Hospitals Ltd. Shareholding Pattern
Quarterly breakdown of Jupiter Life Line Hospitals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Jupiter Life Line Hospitals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Jupiter Life Line Hospitals Ltd.?
The current share price of Jupiter Life Line Hospitals Ltd. is ₹ 314.50 as of 13 Aug 2026.
What is the market capitalisation of Jupiter Life Line Hospitals Ltd.?
The market capitalisation of Jupiter Life Line Hospitals Ltd. stands at ₹ 10,057.80 Cr.
What is the PE ratio of Jupiter Life Line Hospitals Ltd.?
The Price-to-Earnings (PE) ratio of Jupiter Life Line Hospitals Ltd. is 53.61 as of the latest trailing twelve months data.
What is the ROE and ROCE of Jupiter Life Line Hospitals Ltd.?
Jupiter Life Line Hospitals Ltd. has a Return on Equity (ROE) of 13.38% and a Return on Capital Employed (ROCE) of 13.18% as per the latest financial reports.
What is the 52-week high and low of Jupiter Life Line Hospitals Ltd.?
The 52-week high of Jupiter Life Line Hospitals Ltd. is - and the 52-week low is -.
What is the dividend yield of Jupiter Life Line Hospitals Ltd.?
The dividend yield of Jupiter Life Line Hospitals Ltd. is 0.07% based on the current market price.
What is the FII and DII holding in Jupiter Life Line Hospitals Ltd.?
Foreign Institutional Investors (FII) hold 9.37%, Domestic Institutional Investors (DII) hold 12.90% and retail/public investors hold 30.61% of Jupiter Life Line Hospitals Ltd. shares.
What sector does Jupiter Life Line Hospitals Ltd. belong to?
Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector. 60% of analysts have a Buy or Strong Buy rating on Jupiter Life Line Hospitals Ltd. with a consensus target price of ₹ 320.00, implying 4.3% upside from current levels.
What is the beta of Jupiter Life Line Hospitals Ltd.?
The beta of Jupiter Life Line Hospitals Ltd. is 0.23, indicating its price volatility relative to the broader market. Over the past 1 year, Jupiter Life Line Hospitals Ltd. has delivered an absolute return of 5.81%.
What is the RSI of Jupiter Life Line Hospitals Ltd.?
The 14-day Relative Strength Index (RSI) of Jupiter Life Line Hospitals Ltd. is 45.96, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Jupiter Life Line Hospitals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong price momentum
Price Momentum score of 79.7 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
79.7 / 100
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.38 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.09 in the last 1 year
What is Debt to Equity?
Negative
Expensive and at same valuation levels as industry median P/E
PE TTM of 53.61 indicates that the stock is expensive on a standalone basis. Premium to industry median P/E is modest at 6.24%
What is P/E Ratio?
Median: 50.46
Value 53.61
13.961638.05
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -3.84% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Moderate ROE but declining trend
The company reported moderate ROE of 13.38% for 12-month ended 30 Jun 2026 but ROE declined by -194 bps from 1 year ago
What is ROE (FY)?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -2.66% for 12-month ended 30 Jun 2026 and the growth was 14.24 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.07%
What is Dividend yield?
Neutral
High operating margin but declining trend
The company reported strong operating margin of 16.13% for 12-month ended 30 Jun 2026 but operating margin declined by -229 bps from 1 year ago
What is Operating profit margin?
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 17.83% for 12-month ended 30 Jun 2026 and the growth was 0.13 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 17.96
Value 17.83
-0.8760.59
Company's earnings are of moderate quality
Earnings quality score of 55.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
55.0 / 100
No red flags found!
No significant red flags found in the stock.
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Overview of Jupiter Life Line Hospitals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Jupiter Life Line Hospitals Limited is a provider of advanced multi-specialty quaternary healthcare. Its services include cardiology, oncology, dermatology, gastroenterology, orthopedics, infectious diseases, nephrology, nutrition and dietetics, neurology and neurosciences, pediatrics, organ transplant, hematology, rheumatology, urology, endocrinology and diabetes, and ophthalmology. It offers 30+ clinical specialties, supported by cutting-edge diagnostics, specialized surgical capabilities, and dedicated critical care infrastructure. It offers medical technologies to support complex procedures and minimally invasive treatments, such as robotic-assisted surgical systems, interventional radiology capabilities, hematology and bone marrow transplant unit, integrated diagnostic imaging and laboratory services, and comprehensive rehabilitation services. Its technologies include sleep labs and cognitive rehabilitation systems and endoscopic ultrasound and endobronchial ultrasound.
Jupiter Life Line Hospitals Limited is a provider of advanced multi-specialty quaternary healthcare. Its services include cardiology, oncology, dermatology, gastroenterology, orthopedics, infectious diseases, nephrology, nutrition and dietetics, neurology and neurosciences, pediatrics, organ transpl...